07Dec
Private Equity Dealmakers Guidebook to Healthcare M&A During the Covid-19 Pandemic
The COVID-19 pandemic has stressed the M&A market at every stage of the deal-making process – from complicating on-site visits and intensifying the diligence process to introducing valuation gaps (relative to pre-COVID-19 expectations), complicating purchase agreement negotiations and limiting the availability of debt financing. Despite these hurdles, healthcare dealmakers have continued to pursue attractive acquisition opportunities throughout 2020, with the healthcare M&A market substantially...
By:
Bass, Berry & Sims PLC
Related
As the end of the year approaches, there are several legal considerations and tasks that businesses ...
Read More >
Proskauer’s 24th Annual Trick or Treat Seminar was held on Wednesday, October 31 and discussed time...
Read More >
The City of Pittsburgh has announced that its Paid Sick Days Act (the “Act”) will become effective...
Read More >
On Tuesday, September 24, 2019, the U.S. Department of Labor (DOL) issued the final version of its l...
Read More >
Make no mistake, the antitrust laws remain in full effect. The leadership of the Antitrust Division...
Read More >
The fight over the scope of the “ABC test” for determining the status of workers under California ...
Read More >